IVI RMA Global Expands Fertility Services in UAE and Saudi Arabia with ART Fertility Clinics Acquisition

IVI RMA Global acquires ART Fertility Clinics operations in the UAE and Saudi Arabia, expanding its footprint in the GCC region. The acquisition includes three state-of-the-art clinics and strengthens IVI RMA Global's presence in the region. ART Fertility Clinics is known for its research-based protocols and high IVF success rates. The deal is subject to regulatory conditions and marks a strategic move by IVI RMA Global to grow its network while maintaining quality standards.

IVI RMA Global, a leading platform in reproductive medicine, has acquired the operations of ART Fertility Clinics in the United Arab Emirates (UAE) and Saudi Arabia. The acquisition includes three state-of-the-art clinics, further solidifying IVI RMA Global's presence in the GCC region. The deal, subject to regulatory conditions, marks a strategic move by IVI RMA Global to expand its network while maintaining its commitment to quality standards [1].

ART Fertility Clinics, known for its research-based protocols and high IVF success rates, will now operate under the IVI RMA Global banner. The acquisition will enable IVI RMA Global to provide personalized fertility treatments based on evidence-based medicine and proprietary research-based protocols, ensuring patient safety and satisfaction. This move comes as the GCC region continues to see growing demand for specialty medical services, driven by a rising middle class and increased disposable incomes [1].

The acquisition is part of IVI RMA Global's broader strategy to become a hub for international patients and a driver in the development of the fertility sector in the region. The company, which now operates more than 200 fertility clinics across 15 countries, aims to maintain its position as one of the most comprehensive, patient-focused, and science-led fertility networks in the world [2].

The deal underscores the rising interest of private equity firms in the GCC healthcare sector. Gulf Capital PJSC, the majority shareholder in ART Fertility Clinics, has been involved in several successful exits in the region, including the sale of IVI RMA's Middle East operations five years ago [1].

IVI RMA Global's acquisition of ART Fertility Clinics is a testament to its commitment to science, innovation, and patient well-being, aligning with the core values of ART Fertility Clinics. The partnership will bring together two organizations dedicated to delivering the highest level of fertility care, backed by scientific evidence and research [2].

References:
[1] https://www.bloomberg.com/news/articles/2025-07-30/kkr-backed-firm-buys-gulf-capital-s-mideast-fertility-business
[2] https://www.businesswire.com/news/home/20250730944788/en/IVI-RMA-Global-Expands-Footprint-in-Reproductive-Medicine-with-Acquisition-of-ART-Fertility-Clinics-in-the-United-Arab-Emirates-and-Saudi-Arabia